FLT3 and acute myeloid leukemia: ORR in FLT3 (+)—80%ORR in FLT3 WT—4/11 (36.4%)-120 mg/d gilteritinib, recommend→ gilteritinib, well tolerated and effectivein Japanese R/R AML pts.